1. Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants 
J.W. Eikelboom, S. Kozek-Langenecker, A. Exadaktylos, A. Batorova, Z. Boda, F. Christory, I. Gornik, G. Kėkštas, A. Kher, R. Komadina, O. Koval, G. Mitic, T. Novikova, E. Pazvanska, S. Ratobilska, J. Sütt, A. Winder, D. Zateyshchikov 
British Journal of Anaesthesia 
Volume 120, Issue 4, Pages (April 2018)
DOI: /j.bja
Copyright © 2017 The Author(s) Terms and Conditions

2. Fig 1
Management of bleeding in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). aPCC, activated prothrombin complex concentrate; PCC, prothrombin complex concentrate; recombinant activated factor, rFVIIa.
British Journal of Anaesthesia  , DOI: ( /j.bja )
Copyright © 2017 The Author(s) Terms and Conditions

3. Fig 2
Management of non-vitamin K antagonist oral anticoagulant (NOAC)-treated patients who require an emergency surgical or invasive procedure. aPCC, activated prothrombin complex concentrate; PCC, prothrombin complex concentrate; recombinant activated factor, rFVIIa.
British Journal of Anaesthesia  , DOI: ( /j.bja )
Copyright © 2017 The Author(s) Terms and Conditions